Safety, Tolerability and Pharmacokinetic Profile of BIA 2-093, a Novel Putative Antiepileptic Agent, during First Administration to Humans

Author： Almeida L.   Soares-da-Silva P.  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.4, Iss.5, 2003-01, pp. : 269-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Food on the Pharmacokinetic Profile of Eslicarbazepine Acetate (BIA 2-093)

By Maia Joana   Vaz-da-Silva Manuel   Almeida Luis   Falcão Amilcar   Silveira Pedro   Guimarães Serafim   Graziela Patricia   Soares-da-Silva Patricio  

Drugs in R&D, Vol. 6, Iss. 4, 2005-01 ,pp. : 201-206

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of BIA 3-202, a Novel COMT Inhibitor, during First Administration to Humans

By Almeida L.   Soares-da-Silva P.  

Drugs in R&D, Vol. 4, Iss. 4, 2003-01 ,pp. : 207-217

Adis International

Access to resources Recommend Favorite

Effect of Food on the Pharmacokinetic Profile of Etamicastat (BIA 5-453)

By Vaz-da-Silva Manuel  

Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. : 127-136

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Bismuthyl Ecabet Suspension, a Novel Anti-Ulcer Agent, following Single and Multiple Oral Dose Administration in Healthy Chinese Subjects

By Wang Yongqing  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 247-252

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Antiepileptic Drug Treatment in Children with Epilepsy

By Guerrini Renzo  

Drug Safety, Vol. 35, Iss. 7, 2012-07 ,pp. : 519-533

Adis International

Access to resources Recommend Favorite